Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Increasing quality of life and reducing HIV burden: the PATH+ intervention.

Blank MB, Hennessy M, Eisenberg MM.

AIDS Behav. 2014 Apr;18(4):716-25. doi: 10.1007/s10461-013-0606-x.

2.

A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness.

Blank MB, Hanrahan NP, Fishbein M, Wu ES, Tennille JA, Ten Have TR, Kutney-Lee AM, Gross R, Hines JM, Coyne JC, Aiken LH.

Psychiatr Serv. 2011 Nov;62(11):1318-24. doi: 10.1176/ps.62.11.pss6211_1318.

3.

Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.

Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD.

MMWR Surveill Summ. 2011 Sep 2;60(11):1-20.

4.

Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.

Silveira MP, Maurer P, Guttier MC, Moreira LB.

J Clin Pharm Ther. 2015 Apr;40(2):192-5. doi: 10.1111/jcpt.12233. Epub 2014 Nov 25.

PMID:
25422132
5.

Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literature.

Kenya S, Chida N, Symes S, Shor-Posner G.

HIV Med. 2011 Oct;12(9):525-34. doi: 10.1111/j.1468-1293.2011.00921.x. Epub 2011 Apr 24. Review.

6.

Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.

Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH.

J Urban Health. 2003 Sep;80(3):416-27.

7.

Using community health workers to improve clinical outcomes among people living with HIV: a randomized controlled trial.

Kenya S, Jones J, Arheart K, Kobetz E, Chida N, Baer S, Powell A, Symes S, Hunte T, Monroe A, Carrasquillo O.

AIDS Behav. 2013 Nov;17(9):2927-34. doi: 10.1007/s10461-013-0440-1.

8.

Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).

Rothbard AB, Lee S, Blank MB.

J Ment Health Policy Econ. 2009 Dec;12(4):187-94.

PMID:
20195006
9.

A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.

Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR.

Arch Gen Psychiatry. 2010 Dec;67(12):1282-90. doi: 10.1001/archgenpsychiatry.2010.160.

10.

Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.

J Ment Health Policy Econ. 2009 Mar;12(1):33-46.

PMID:
19346565
11.

Testing a nurse-tailored HIV medication adherence intervention.

Holzemer WL, Bakken S, Portillo CJ, Grimes R, Welch J, Wantland D, Mullan JT.

Nurs Res. 2006 May-Jun;55(3):189-97.

PMID:
16708043
12.

Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.

Berg KM, Litwin AH, Li X, Heo M, Arnsten JH.

Clin Infect Dis. 2011 Nov;53(9):936-43. doi: 10.1093/cid/cir537. Epub 2011 Sep 2.

13.

Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS.

Young T, Busgeeth K.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005417. doi: 10.1002/14651858.CD005417.pub2. Review.

PMID:
20091575
14.

Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.

Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, Niyigena P, Walker KD, Epino H, Binagwaho A, Mukherjee J, Farmer PE, Rich ML.

Clin Infect Dis. 2013 May;56(9):1319-26. doi: 10.1093/cid/cis1193. Epub 2012 Dec 18.

PMID:
23249611
15.

Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.

Blair JM, Fagan JL, Frazier EL, Do A, Bradley H, Valverde EE, McNaghten A, Beer L, Zhang S, Huang P, Mattson CL, Freedman MS, Johnson CH, Sanders CC, Spruit-McGoff KE, Heffelfinger JD, Skarbinski J; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.

MMWR Suppl. 2014 Jun 20;63(5):1-22.

PMID:
24941443
16.

Improving adherence and clinical outcomes through an HIV pharmacist's interventions.

Ma A, Chen DM, Chau FM, Saberi P.

AIDS Care. 2010 Oct;22(10):1189-94. doi: 10.1080/09540121003668102.

PMID:
20640958
17.

Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.

Nachega JB, Mutamba B, Basangwa D, Nguyen H, Dowdy DW, Mills EJ, Katabira E, Nakimuli-Mpungu E.

Trop Med Int Health. 2013 Jan;18(1):53-7. doi: 10.1111/tmi.12019. Epub 2012 Nov 8.

18.

Tailored treatment for HIV+ persons with mental illness: the intervention cascade.

Blank MB, Eisenberg MM.

J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S44-8. doi: 10.1097/QAI.0b013e318293067b. Review.

19.

A programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients.

Chiou PY, Kuo BI, Lee MB, Chen YM, Chuang P, Lin LC.

J Adv Nurs. 2006 Jul;55(2):169-79.

PMID:
16866809
20.

Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.

Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP.

J Manag Care Pharm. 2009 Jan-Feb;15(1):32-41.

Supplemental Content

Support Center